Francois Mbonyinshuti

Mr. Francois Mbonyinshuti

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2021 in Processes
Verified
Journal Article
Open access
PDF file
FMFrancois Mbonyinshuti
Francois Mbonyinshuti
JNJoseph Nkurunziza
Joseph Nkurunziza
JNJaphet Niyobuhungiro
Japhet Niyobuhungiro
EKEgide Kayitare
Egide Kayitare
Today’s global business trends are causing a significant and complex data revolution in the healthcare industry, culminating in the use of artificial intelligence and predictive modeling to improve health outcomes and performance. The dataset, which was referred to is based on consumption data from 2015 to 2019, included approximately 500 goods. Based on a series of data pre-processing activities, the top ten (10) essential medicines most used were chosen, namely cotrimoxazole 480 mg, amoxicillin 250 mg, paracetamol 500 mg, oral rehydration salts (O.R.S) sachet 20.5 g, chlorpheniramine 4 mg, nevirapine 200 mg, aminophylline 100 mg, artemether 20 mg + lumefantrine (AL) 120 mg, Cromoglycate ophthalmic. Our study concentrated on the application of machine learning (ML) to forecast future trends in the demand for essential drugs in Rwanda. The following models were created and applied: linear regression, artificial neural network, and random forest. The random forest was able to predict 10 selected medicines with an accuracy of 88 percent with the train set and 76 percent with the test set, and it can thus be used to forecast future demand based on past consumption data by inputting a month, year, district, and medicine name. According to our findings, the random Forest model performed well as a forecasting model for the demand for essential medicines. Finally, data-driven predictive modeling with machine learning (ML) could become the cornerstone of health supply chain planning and operational management.

2 June 2022 in Pan African Medical Journal
Verified
Journal Article
Open access
FMFrancois Mbonyinshuti
Francois Mbonyinshuti
JNJoseph Nkurunziza
Joseph Nkurunziza
JNJaphet Niyobuhungiro
Japhet Niyobuhungiro
EKEgide Kayitare
Egide Kayitare
INTRODUCTION: Recent initiatives in healthcare reform have pushed for a better understanding of data complexity and revolution. Given the global prevalence of Non-Communicable Diseases (NCD) and the economic and clinical burden they impose, it is recommended that the management of essential medicines used to treat them be renovated and optimized through the application of predictive modeling such a RF model. METHODS: in this study, a series of data pre-processing activities were used to select the top seventeen (17) NCD essential medicines most commonly used for treating common and frequent NCD. The study focused on machine learning (ML) applications, whereby a random forest (RF) model was applied to predict the demand using essential medicines consumption data from 2015 to 2019 for approximately 500 medical products. RESULTS: with a seventy-eight (78) percent accuracy rate for the training set and a 71 percent accuracy rate for the testing set, the RF model predicted the trend in demand for 17 NCD essential medicines. This was achieved by entering the month, year, district, and name of the NCD essential medicine. Based on historical consumption data, the RF model can thus be used to predict demand trends. Our findings showed that the RF model is talented to commendably perform as a predicting model. CONCLUSION: the study concluded that RF has the ability to optimize health supply chain planning and operational management by boosting the accuracy in predicting the demand trend for NCD essential medicines.

1 March 2021 in Public Health Action
Verified
Journal Article
Closed access
FMFrancois Mbonyinshuti
Francois Mbonyinshuti
KTK. C. Takarinda
K. C. Takarinda
SAS. Ade
S. Ade
MMM. Manzi
M. Manzi
Patrick Gad IRADUKUNDAPatrick Gad IRADUKUNDA
Patrick Gad IRADUKUNDA
PKP. C. Kayumba
P. C. Kayumba
SETTING: Hypertension, diabetes mellitus and asthma are on the rise in developing countries, including Rwanda; there is thus a need to ensure uninterrupted drug availability. OBJECTIVES: To assess 1) the frequency and duration of drug stock-outs; 2) lead time duration 3) monthly stock levels; and 4) drug quantities requested vs. quantity delivered for captopril, metformin and inhaled salbutamol between January and December 2018 Kirehe District, Rwanda. DESIGN: This was a cross-sectional study using secondary programme data. RESULTS: The median annual stock-outs for captopril, metformin and inhaled salbutamol were respectively 4 (IQR 3–4), 3 (IQR 2–3) and 4 (IQR 4–5) at rural health facilities (RHCs); no stock-outs occurred at the district hospital. For all three drugs, the median lead time was 7.5 days (IQR 5.5–11.5) at the hospital vs. 5 days (IQR 3–6) in RHCs. Stock status for captopril was below the 4-week minimum stock level for 2/12 months at the hospital vs. 7/12 months at the RHCs, while metformin and inhaled salbutamol were below the 4-week minimum stock levels for respectively 1/12 and 4/12 months at both hospital and RHCs. Total drug quantities delivered were less than the combined total quantities requested in respectively 8/12, 5/12 and 8/12 months for captopril, metformin and inhaled salbutamol. CONCLUSION: There is a need to regularly and effectively monitor drug stock levels and ensure timely and sufficient stock replenishment to avert stock-outs.